Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132236) titled 'A clinical study to evaluate the safety, tolerability, biodistribution, radiation dosimetry, and preliminary diagnostic efficacy of 68Ga-BIBD-492 in patients with malignant tumors' on Sept. 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

Condition: malignant tumor

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-15

Target Sample Size: intervention Group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=339515

Published by HT Digi...